With more than 1.2 billion people, India is the world’s second most populous nation, after China, and the country’s real GDP continues to grow significantly. In addition to robust economic advancement, India is expanding its healthcare infrastructure and improving its quality of healthcare.
Sysmex values India’s market for in-vitro diagnostics at around US$500 million, or approximately one-eighth that of Japan. Moreover, the Company expects this market to grow at a rapid annual pace of around 12–16%, as India’s healthcare infrastructure expands and its quality of healthcare improves.
Since Sysmex selected Transasia Bio-Medicals Ltd. as its Indian distributor in 1993, the two companies have worked together to expand sales and support networks in India. In 1998, Sysmex established a joint venture with Transasia Bio-Medicals (now, Sysmex India) and began manufacturing reagents. In 2007, the company established a reagent factory in Baddi, and in 2008 Sysmex converted the company to a wholly owned subsidiary. In this manner, Sysmex established a business base in India, centered on the field of hematology, and promoted sales and support through local distributors.
Sysmex has been offering direct sales and support in the urinalysis field. Recently, we have also commenced direct sales and support in the fields of hemostasis and clinical chemistry, anticipating further business expansion in line with India’s economic growth, increasing population and progress on healthcare infrastructure.
By offering direct sales and support, Sysmex aims to foster direct customer communications, enabling it to provide solutions to the diverse issues customers face. This approach should also allow Sysmex to step up its activities involving scientific seminars—an area of strength—as part of its aim to be a comprehensive supplier in India.
In the hematology field, Sysmex will continue working with its local distributor, augmenting its distributor support structure even further.
Going forward, Sysmex aims to strengthen its sales and support network and provide Sysmex support services as it strives to contribute to the development of healthcare.
Outline of Sysmex India
Name: Sysmex India Pvt. Ltd.
Location: Mumbai, Maharashtra State (HQ); Himachal Pradesh State (factory)
Representative: Atsuhito Koyama
Capital: 118,000,000 INR
Capital supplied by: Sysmex Corporation, 17%
Sysmex Asia Pacific Pte Ltd., 83%
(Sysmex Asia Pacific is a wholly owned subsidiary of Sysmex Corporation.)
Employees: 43 (As of April 2014)
Line of business: Sales of in-vitro diagnostic instruments and reagents in India and provision of related after-sales support, as well as supporting distributors